News

Cirdan acquires Philips PathXL business

Published on: 27/07/2020

Cirdan acquires Philips PathXL business
Member News

Medical informatics and imaging technology company, Cirdan has today announced that it has acquired the Belfast-based Philips Digital and Computational Pathology business (formerly known as PathXL).

Headquartered in Northern Ireland with offices in Canada and Australia, Cirdan specialises in developing technology that supports and speeds up diagnosis, primarily used by those working in pathology. The company’s main products are ULTRA, a Laboratory Information System which supports the operations of multiple public and private labs across the world, and CoreLite, an x-ray system that helps expedite breast cancer diagnosis.

Philips PathXL’s digital pathology, image analysis, deep learning and educational tools will complement Cirdan’s existing offering, and the synergies of both products and staff will significantly enhance opportunities to serve their customers across the world.

Speaking about the acquisition, Cirdan CEO, Dr. Hugh Cormican commented:

“We are excited by the prospect of being able to further invest in our laboratory informatics business with this acquisition. We have shared a close relationship with key members of the PathXL team over many years and are looking forward to combining our products and resources to bring the best of each to the industry. It has been our long-term vision for our products to be global technological leaders, and with the addition of PathXL we will be able to accelerate the inclusion of deep learning and digital pathology technology.”

PathXL was founded in 2004 as a Queen’s University Belfast spin out company and was purchased by Philips in 2016. It offers a range of digital pathology software applications for research and education addressing growing segments of the pathology market including bio-pharma.

Deep Learning is a form of Artificial Intelligence (AI) that focuses on solving real world problems from deep neural networks that mimic the way our brain makes decisions.

NEWS​

Related News

Open innovation challenge advances clinical data capture in Switzerland

28 Aug 2025
The Digital Health Nation Innovation Booster, powered by Innosuisse and led by DayOne, launched an Open Innovation Challenge to address fragmented, in...

EVITA joins HECADE: Strengthening Europe’s voice for hereditary cancer patients through collaboration

28 Aug 2025
EVITA, a Portuguese non-profit supporting individuals affected by hereditary cancer, has officially joined HECADE, a European network of patient organ...

ZimSmart Villages Championing Universal Health Access in Zimbabwe

27 Aug 2025
By harnessing the power of telehealth and digital innovation, ZimSmart Villages is not just bridging the gaps in Zimbabwe's healthcare system; it is b...

Germany – Medical Valley EMN Ecosystem is ECHAlliance Ecosystem of the Month – September

27 Aug 2025
This month we are featuring our Germany - Medical Valley EMN Ecosystem as our Ecosystem of the Month.

Manetu, a global leader in policy-based governance and knowledge protection

26 Aug 2025
Operating worldwide, Manetu partners with enterprises, technology providers, and standards bodies to shape the future of AI governance. From financial...

CTS: your go-to growth accelerator dedicated to healthtech startups

26 Aug 2025
Leveraging a global network of entrepreneurs, scientists, investors, and industry leaders in technology and life sciences, CTS’s mission is to catalyz...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *